Assura Plc (LON:AGR – Get Free Report)’s stock price shot up 11.6% during mid-day trading on Monday . The stock traded as high as GBX 46.20 ($0.58) and last traded at GBX 43.52 ($0.55). 212,891,641 shares were traded during mid-day trading, an increase of 1,382% from the average session volume of 14,366,552 shares. The stock had previously closed at GBX 39 ($0.49).
Assura Trading Up 11.7 %
The business has a 50 day moving average of GBX 37.60 and a 200 day moving average of GBX 39.70. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84. The firm has a market capitalization of £1.42 billion, a price-to-earnings ratio of -41.62, a PEG ratio of 3.60 and a beta of 0.37.
Assura (LON:AGR – Get Free Report) last announced its quarterly earnings results on Thursday, November 14th. The real estate investment trust reported GBX 1.70 ($0.02) earnings per share for the quarter. Assura had a negative net margin of 18.09% and a negative return on equity of 1.92%. As a group, research analysts predict that Assura Plc will post 3.5830389 earnings per share for the current fiscal year.
Assura Dividend Announcement
Assura Company Profile
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Further Reading
- Five stocks we like better than Assura
- How to Calculate Options Profits
- Is Coinbase Stock a Buy After Earnings?
- What Are Dividend Achievers? An Introduction
- 3 Stocks to Hedge Against Inflation’s Persistence
- 3 Healthcare Dividend Stocks to Buy
- Dominion Energy: Renewable Energy Lights Up Investor Optimism
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.